However, the effects of direct genetic manipulation of DYRK1A in the brain on cognitive function, neuroinflammation and Alzheimer’s disease (AD) pathology and underlying molecular mechanisms have not been fully investigated. This evidence concerns the gene DYRK1A and early-onset autosomal dominant Alzheimer disease.